Prostate cancer screening may not reduce deaths
Men are being urged to consider risks before undergoing prostate cancer screening in the wake of two studies that did not produce convincing evidence that routine testing significantly reduces the chance of dying from the disease. The PSA blood test, which millions of men undergo each year, did not lower the death toll from the disease in the first decade of a U.S. government-funded study involving more than 76,000 men, researchers reported.
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Interventional Radiology No Longer a Sub-Specialty
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- MA an Insurance Proving Ground for Providers
- Sharp HealthCare Leaves Pioneer ACO Program
- Evidence-Based Practice and Nursing Research: Avoiding Confusion